Back
ESC Professional Premium Access

Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome

Session: Ion channel diseases: risk stratification and treatment
Topic: Ion Channel Disorders
Speaker: Doctor J. Isbister (Sydney, AU)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Julia Clair Isbister

Centenary Institute, Sydney (Australia)
1 presentation
0 follower

7 more presentations in this session

An online international survey study into the incidence and potential reasons of therapy non-adherence in catecholaminergic polymorphic ventricular tachycardia: preliminary results

Speaker: Mrs P. Peltenburg (Amsterdam, NL)

Access
Abstract
Slides
Video
Thumbnail

Roles of atrial arrhythmias in triggering torsade de pointes in patients with acquired long QT syndrome

Speaker: Doctor R. Tochibora (Gifu, JP)

Access
Abstract
Slides
Video
Thumbnail

Prevalence and prognostic value of epilepsy and Brugada syndrome

Speaker: Miss E. Rossetto (Milan, IT)

Access
Abstract
Slides
Video
Thumbnail

Characterization of the cardiac and non-cardiac phenotype associated with genetic variants in KCNJ2

Speaker: Doctor D. Abrams (Boston, US)

Access
Abstract
Slides
Video
Thumbnail

Interpretable machine learning model using Extreme Gradient Boosting with Nonnegative Matrix Factorization improves the accuracy of arrhythmic risk prediction in Brugada Syndrome

Speaker: Professor G. Tse (Hong Kong, CN)

Access
Abstract
Slides
Thumbnail

Access the full session

Ion channel diseases: risk stratification and treatment

Speakers: Doctor J. Isbister, Mrs P. Peltenburg, Doctor R. Tochibora, Miss E. Rossetto, Doctor D. Abrams...
Access
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb